Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
Eva Tiensuu Janson(Uppsala University), Ulrich Knigge(Copenhagen University Hospital), Anders Sundin, Espen Thiis‐Evensen(Oslo University Hospital), Jann Mortensen(Copenhagen University Hospital), Per Hellman(Uppsala University Hospital), Staffan Welin, Matti Välimäki(University of Helsinki), Henning Grønbæk(Aarhus University Hospital), Birgitte Federspiel(University of Copenhagen), Øystein Mathisen(Oslo University Hospital), Kjell Öberg(Uppsala University Hospital), Halfdan Sørbye(Haukeland University Hospital)
Cited by 77
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
K <sup>+</sup> Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
|Science|2011|983
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951